Home » Newsletters » BioWorld Science

BioWorld Science

July 30, 2003

View Archived Issues

Clinical trial results for emtricitabine discussed at HIV meeting

Lipid-lowering effects described for YM-53601 in rodents

Roche to acquire IGEN

Oritavancin combination therapy in pneumococcal meningitis

CRL-42796 prevents carotid artery thrombosis in dogs

Improved pulmonary hypertension in sickle cell disease after oral L-arginine supplementation

Single dose of NN-2211 restores beta-cell responsiveness in type 2 diabetes

Olprinone and the management/prevention of fatigue in diaphragm contractility

Durable remission following treatment with i.m. alefacept in chronic plaque psoriasis

Adolor obtains North American rights to EpiCept's lidocaine patch

NicOx reviews first-half achievements

Vertex: Q2 accomplishments

Positive opinion handed down in Europe for new Synagis indication

Advate approved for bleeding episodes in patients with hemophilia A

CPMP recommends approval of Remicade for maintenance dosing in fistulizing CD

Approval of Xagrid recommended in Europe

Emend receives positive opinion from European CPMP

Wyeth patents cover novel 5-HT6 receptor ligands and potential uses

Novel antibacterial series described by Bayer

Preparation and use of inhibitors of the expression of VCAM-1 described by AtheroGenics

Compositions of dextrin sulfate for STDs claimed by ML Laboratories

Solid controlled-release formulations of known antidepressant

Icogen receives SBIR grant to fund identification of Alzheimer's therapeutic

Potential chemopreventive agents in development at SRI

Feasibility of PACT approach to solid tumor therapy demonstrated using CVS-10290

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...